Now published in ESMO Perspectives digital magazine, the latest edition of On Target – Artificial Intelligence: a ‘smart’ arrow in our quiver against cancer – focuses on AI in oncology and how it is increasingly enhancing personalized cancer treatment and care by potentiating diagnostic capability and improving the molecular characterization of tumors and their microenvironment.
In her October column, On Target’s author Elena Garralda, Director of our Research Unit for Molecular Therapy of Cancer (UITM) – CaixaResearch, and Principal Investigator of our Early Clinical Drug Development Group, highlights just a few of the many studies presented during last month’s ESMO Congress 2022 that point to the promise of AI in generating deeper insights, enhancing cancer patient stratification, improving drug response prediction, and anticipating disease evolution, progression and relapse.
To read this ESMO Perspectives On Target and access Elena Garralda’s past editions please click here.
